Search Results

Displaying Results 651-675 of 1180 "'EC'"

Mar 24, 2026, 07:55 ET Yêu cầu cả xét nghiệm ESR và CRP có thể giúp các bệnh viện tiết kiệm hàng triệu đô la mỗi năm -- Nghiên cứu mới thách thức quan niệm cho rằng hai xét nghiệm này có thể thay thế cho nhau

content:https://www.prnewswire.com/vn/news-releases/u0079u0065u0075u002Du0063u1EA7u0075u002Du0063u1EA3u002Du0078u0065u0074u002Du006Eu0067u0068u0069u1EC7u006Du002Du0065u0073u0072u002Du0076u0061-302723311.htmlSOURCE

More news about: Alcor Scientific


Mar 24, 2026, 07:01 ET Karyopharm Announces $30 Million Private Placement with RA Capital

warrants will be immediately exercisable and will expire 30 days following the public announcement by the Company of topline results from the Phase 3 XPORT-EC-042 clinical trial of selinexor in patients with endometrial cancer.The private placement is expected to close on or about March 26, 2026, subject

More news about: Karyopharm Therapeutics Inc.


Mar 24, 2026, 03:43 ET DualityBio (9606.HK) Announces 2025 Annual Results

acceptance and review stage. A potential registrational cohort in a global Phase 1/2 trial for HER2-expressing advanced/recurrent Endometrial Cancer ("EC") has completed enrollment, and partner BioNTech plans to submit a BLA to the U.S. Food and Drug Administration ("FDA") in 2026. In addition, the global

More news about: Duality Biotherapeutics, Inc.


Mar 23, 2026, 23:00 ET Sự kiện Tết tại Đông Nam Á của WePlay được App Store Today đề xuất cả trong chuyên mục đặc biệt lẫn danh sách tổng hợp

multimedia:https://www.prnewswire.com/vn/news-releases/u0073u1EF1u002Du006Bu0069u1EC7u006Eu002Du0074u1EBFu0074u002Du0074u1EA1u0069u002Du0111u006Fu006Eu0067u002Du006Eu0061u006Du002Du0061u002Du0063-302721642.htmlSOURCE

More news about: WEJOY PTE. LTD.


Mar 23, 2026, 22:31 ET KELUN-BIOTECH ANNOUNCED 2025 ANNUAL RESULTS: MULTIPLE PRODUCTS SUCCESSFULLY LAUNCHED WITH TIERED PIPELINE READY FOR TAKE-OFF

actively exploring the potential of sac-TMT both as a monotherapy and in combination with other therapies for treating other solid tumors, including GC, EC, CC, OC, UC, CRPC, HNSCC, and TC, etc.Trastuzumab botidotin (HER2 ADC, also known as A166, 舒泰莱®)

More news about: Kelun-biotech


Mar 23, 2026, 21:15 ET ICP DAS-BMP giới thiệu toàn bộ danh mục đổi mới TPU y tế tại CMEF và Medtec Japan 2026

multimedia:https://www.prnewswire.com/vn/news-releases/u0069u0063u0070u002Du0064u0061u0073u002Du0062u006Du0070u002Du0067u0069u1EDBu0069u002Du0074u0068u0069u1EC7u0075u002Du0074u006Fu0061u006Eu002D-302711691.htmlSOURCE

More news about: ICP DAS Co., Ltd.


Mar 23, 2026, 11:00 ET Green Cement Market to Reach US$ 74.4 Billion by 2033 Expands Amid Decarbonization and Sustainable Construction Demand as per PMR

environment.ContactRitika KhandelwalPersistence Market ResearchSecond Floor, 150 Fleet Street, London, EC4A 2DQ+44 203-837-5656United KingdomUSA Phone - +1 646-878-6329Email: 

More news about: Persistence Market Research Pvt. Ltd.


Mar 23, 2026, 10:16 ET Refurbished and Used Mobile Phones Market to Reach US$ 135.4 Billion by 2033 Expands Amid Circular Economy and Affordable Smartphone Demand - Persistence Market Research

competitive environment.ContactRitika KhandelwalPersistence Market ResearchSecond Floor, 150 Fleet Street, London, EC4A 2DQ+44 203-837-5656United KingdomUSA Phone - +1 646-878-6329Email: 

More news about: Persistence Market Research Pvt. Ltd.


Mar 23, 2026, 10:01 ET Animal Drug Compounding Market to Reach US$ 2.3 Billion by 2033, Expands Amid Rising Pet Healthcare Demand and Personalized Veterinary Medicine - Persistence Market Research

environment.ContactRitika KhandelwalPersistence Market ResearchSecond Floor, 150 Fleet Street, London, EC4A 2DQ+44 203-837-5656United KingdomUSA Phone - +1 646-878-6329Email: 

More news about: Persistence Market Research Pvt. Ltd.


Mar 23, 2026, 04:42 ET KuCoin hiện thực hóa "Dẫn lối tương lai" tại Tomorrowland Winter, kết nối âm nhạc, văn hóa và niềm tin

multimedia:https://www.prnewswire.com/vn/news-releases/u006Bu0075u0063u006Fu0069u006Eu002Du0068u0069u1EC7u006Eu002Du0074u0068u1EF1u0063u002Du0068u006Fu0061u002Du0022u0064u0061u0303u006Eu002Du006C-302721868.htmlSOURCE

More news about: KuCoin


Mar 22, 2026, 20:00 ET Khám phá tương lai công nghệ sản xuất ô tô tại AMTS 2026, Thượng Hải, Trung Quốc - Đăng ký ngay để nhận vé miễn phí

multimedia:https://www.prnewswire.com/vn/news-releases/u006Bu0068u0061u006Du002Du0070u0068u0061u002Du0074u01B0u01A1u006Eu0067u002Du006Cu0061u0069u002Du0063u006Fu006Eu0067u002Du006Eu0067u0068u1EC7-302720082.htmlSOURCE

More news about: AMTS (Shanghai International Automotive Manufacturing Technology & Material Show)


Mar 20, 2026, 14:23 ET PCHi 2026: Triển lãm nguyên liệu mỹ phẩm lớn nhất thế giới khai mạc tại Hàng Châu

multimedia:https://www.prnewswire.com/vn/news-releases/u0070u0063u0068u0069u002Du0032u0030u0032u0036u003Au002Du0074u0072u0069u1EC3u006Eu002Du006Cu0061u006Du002Du006Eu0067u0075u0079u0065u006Eu002D-302720060.htmlSOURCE

More news about: Reed Sinopharm Exhibitions (RSE)


Mar 20, 2026, 09:03 ET Henlius Reports 2025 Results: Sustained Growth in Both Revenue and Profit, Advancing Innovation Validation and Global Operations

regions worldwide, including 7 products approved in China, 4 products approved by the U.S. FDA, and 4 products authorized by the European Commission (EC), benefiting more than one million patients globally.Dr. Jason Zhu, Executive Director and Chief Executive Officer of Henlius, commented: "2025

More news about: Henlius


Mar 20, 2026, 06:59 ET Agriculture Utility Adjuvants Market worth $2.31 billion by 2031- Exclusive Report by MarketsandMarkets™

industry.The emulsifiable concentrates segment holds a significant market share in the formulation segment.Emulsifiable concentrates (EC) also hold a significant market share in the formulation segment of the utility adjuvants market because of their excellent compatibility and ability

More news about: MarketsandMarkets


Mar 20, 2026, 05:44 ET Điều Cần Biết Khi Bắt Đầu Giao Dịch Vàng - Đánh Giá Toàn Diện Của Justmarkets

multimedia:https://www.prnewswire.com/vn/news-releases/u0111u0069u1EC1u0075u002Du0063u1EA7u006Eu002Du0062u0069u1EBFu0074u002Du006Bu0068u0069u002Du0062u1EAFu0074u002Du0111u1EA7u0075u002Du0067u0069-302719698.htmlSOURCE

More news about: JustMarkets


Mar 19, 2026, 10:01 ET Preimplantation Genetic Testing Market to Reach US$ 1,081.9 Million by 2033 Amid Rising IVF Adoption and Technological Innovation - Persistence Market Research

competitive environment.ContactRitika KhandelwalPersistence Market ResearchSecond Floor, 150 Fleet Street, London, EC4A 2DQ+44 203-837-5656United KingdomUSA Phone - +1 646-878-6329Email: 

More news about: Persistence Market Research Pvt. Ltd.


Mar 18, 2026, 10:01 ET Plant-based Beverage Market to Reach US$71.8 Billion by 2032 Expands Amid Health and Sustainability Trends - Persistence Market Research

environment.ContactRitika KhandelwalPersistence Market ResearchSecond Floor, 150 Fleet Street, London, EC4A 2DQ+44 203-837-5656United KingdomUSA Phone - +1 646-878-6329Email: 

More news about: Persistence Market Research Pvt. Ltd.


Mar 18, 2026, 09:45 ET Scaling Without Overspending: Hyperlink InfoSystem Delivers High Performance with AWS

systems to AWS, achieving a 45% reduction in cloud expenses along with a 3X improvement in application speed and reliability. By leveraging services like EC2, S3, Lambda, and auto-scaling, the solution delivered high availability while eliminating wasteful spending. Businesses looking for effective AWS migration

More news about: Hyperlink InfoSystem


Mar 18, 2026, 06:50 ET Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results

EDTThe European Commission (EC) approved the 2mg/kg every-4-weeks (E4W) dosing regimen for Elfabrio® in adults living with Fabry disease providing a meaningful reduction in treatment burden without compromising efficacyThe EC approval triggered the Company's entitlement

More news about: Protalix BioTherapeutics, Inc.


Mar 18, 2026, 04:00 ET VT 마켓-뉴캐슬 유나이티드, 2026 포렉스 스포츠 어워즈 2관왕

multimedia:https://www.prnewswire.com/kr/news-releases/u0076u0074u002DuB9C8uCF13u002DuB274uCE90uC2ACu002DuC720uB098uC774uD2F0uB4DCu002Cu002Du0032u0030u0032u0036u002DuD3ECuB809uC2A4u002DuC2A4uD3EC-302716964.htmlSOURCE

More news about: VT Markets


Mar 17, 2026, 20:43 ET 【AACR 2026】亞盛醫藥宣佈將在2026年美國癌症研究協會年會上公佈四項最新臨床前進展

Multitarget kinase inhibitor olverembatinib (HQP1351) is efficacious and synergizes with chemotherapy in preclinical models of endometrial carcinoma (EC)多靶點激酶抑制劑奧雷巴替尼(HQP1351)在子宮內膜癌(EC)臨床前模型中具有顯著療效,且與化療聯合時可產生協同增效作用

More news about: 亞盛醫藥


Mar 17, 2026, 11:53 ET Hyperlink InfoSystem Strengthens Its Position as a Leading AI Development Company Through Cutting-Edge AI Solutions

380061IndiaLondon Address:Level 30, The Leadenhall Building,122 Leadenhall Street,London EC3V 4ABCanada Address:151 Yonge Street, 11th Floor,Toronto, Ontario, M5C 2W7,CanadaLogo:

More news about: Hyperlink InfoSystem


Mar 17, 2026, 10:05 ET Distributed Acoustic Sensing Market to Reach US$ 6.5 Billion by 2033 Expands Amid Smart Infrastructure Monitoring and Fiber-Optic Innovation - Persistence Market Research

environment.ContactRitika KhandelwalPersistence Market ResearchSecond Floor, 150 Fleet Street, London, EC4A 2DQ+44 203-837-5656United KingdomUSA Phone - +1 646-878-6329Email: 

More news about: Persistence Market Research Pvt. Ltd.


Mar 17, 2026, 09:07 ET EC Electric Honored with AGC of Washington Safety Team Award

Safety Director at EC Electric.EC Electric remains committed to upholding the highest safety standards, continuously improving its programs, and partnering with organizations like AGC to advance safety throughout the construction industry.About EC ElectricEC Electric is one

More news about: EC Electric


Mar 17, 2026, 06:00 ET Oral Small Molecule Amylin Receptor Agonist ASC39 Demonstrated Eloralintide-like Amylin Selectivity and Efficacy in Preclinical Models

demonstrated similar selectivity and potency to that of eloralintide. EC50  for human amylin 1 receptor (hAMY1R) was 21.4 pM and 21.2 pM for ASC39 and eloralintide, respectively. EC50 for human calcitonin receptor (hCTR) was 846.1 pM and 1,350.8 pM for

More news about: Ascletis Pharma Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.